Cartesian Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Cartesian Therapeutics (RNAC) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Cartesian Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Cartesian Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cartesian Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $63k | 6.1k | 10.22 |
| 2025-03-31 | $2.6M | 195k | 13.18 |
| 2024-12-31 | $4.9M | 275k | 17.91 |
| 2024-09-30 | $5.0M | 309k | 16.12 |
| 2024-06-30 | $8.3M | 306k | 27.01 |